Author

Tobias Schmidt Slørdahl

Norwegian University of Science and TechnologyORCID 0000-0001-7488-4863Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Organism:human· 2 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Assay:imaging· 1

Frequent Co-Authors

Therese StandaliD· 2 shared C. SchilleriD· 1 shared Camilla WolowczykiD· 1 shared Denis SchapiroiD· 1 shared Eline MenuiD· 1 shared Håkon HoviD· 1 shared Håkon Skjalg Selland JohnstueniD· 1 shared Hanne Hella· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 25 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Therese StandalORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Highly multiplexed imaging recovers immune and metabolic niches in multiple myeloma associated with disease progression and bone involvement

Ingrid Aass Roseth, Lukas Hatscher, C. Schiller, Håkon Skjalg Selland Johnstuen, Tobias Schmidt Slørdahl, Håkon Hov, Denis Schapiro, Therese Standal

This study uses spatial analysis to identify immune and metabolic niches in multiple myeloma, finding that CD4+ T cell proximity predicts disease progression.

bioRxiv · Sep 8, 2025 · PreprintCancer Biology

Novel SLAMF1-derived peptide induces apoptosis in multiple myeloma cells by targeting IRF4 transcription factor for degradation

Ingvild Bergdal Mestvedt, Eline Menu, Kristine Misund, Tobias Schmidt Slørdahl, Kashif Rasheed, Camilla Wolowczyk, Hanne Hella, Liv Ryan, Therese Standal, Terje Espevik, Maria Yurchenko

This study identifies a SLAMF1-derived peptide, P7N4, that induces apoptosis in multiple myeloma cells by degrading IRF4, enhancing chemotherapy efficacy and showing minimal toxicity to healthy cells.

bioRxiv · May 7, 2025 · PreprintCancer Biology